LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
40 funds hold it · Insiders net selling
No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 28, 2026
Financial period
Q3 2026
Earnings per share
$4.03 expected
Revenue
$12.00B expected
FY 2026 guidance
$46.50B to $47.50B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 28, 2026 | $4.81est. $4.03 | +19.35%beat | $12.64Best. $12.00B+5.31% | +26.8%from $9.97B |
| Jun 30, 2026Reported Jul 22, 2026 | $2.47est. $3.17 | -22.08%miss | $11.10BCompany release | +21.9%from $9.11B |
| Mar 31, 2026Reported Apr 22, 2026 | $2.01est. $1.67 | +20.38%beat | $9.34BAlpha Vantage | +16.1%from $8.04B |
| Dec 31, 2025Reported Jan 28, 2026 | $12.91est. $3.14 | +$9.77beat | $10.96BAlpha Vantage | +3.8%from $10.56B |
| Sep 30, 2025Reported Oct 22, 2025 | $1.64est. $1.86 | -11.83%miss | $9.97BSEC filing | +11.8%from $8.91B |
| Jun 30, 2025Reported Jul 23, 2025 | $1.86est. $1.64 | +13.41%beat | $9.11BSEC filing | +11.1%from $8.20B |
| Mar 31, 2025Reported Apr 23, 2025 | $0.91est. $0.61 | +49.18%beat | $8.04BAlpha Vantage | +10.8%from $7.26B |
| Dec 31, 2024Reported Jan 22, 2025 | $1.33est. $2.37 | -43.88%miss | $10.56BAlpha Vantage | +5.1%from $10.04B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $10.96B | $9.34B | $11.10B | $12.64B |
| Cost of what it sold | $8.63B | $7.56B | $8.74B | $9.54B |
| Gross profit | $2.32B | $1.78B | $2.36B | $3.11B |
| What it spent | ||||
| Research and development | $366.0M | $304.0M | $334.0M | $358.0M |
| Sales and admin | $1.35B | $1.30B | $1.37B | $1.35B |
| Total operating expenses | $1.72B | $1.60B | $1.71B | $1.71B |
| What was left | ||||
| Operating profit | $601.0M | $179.0M | $655.0M | $1.39B |
| Profit before tax | $1.10B | $5.10B | $925.0M | $1.78B |
| Tax | -$2.56B | $354.0M | $276.0M | $493.0M |
| Net profit | $3.66B | $4.75B | $668.0M | $1.29B |
| EBITDA | $1.33B | $5.45B | $1.34B | $2.22B |
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
GE Vernova to Invest $34.5 Million in Facility Expansion
BullishNov 10Olema Pharmaceuticals Q3 Results: Loss widens 49% YoY to $(0.73)
BearishNov 10Corning to Caterpillar: The AI ‘Picks and Shovels’ Trade Caves In
Leans bearishNov 10S&P 500 Gap-Down Stocks: Nov. 10, 2026 Session
BearishNov 10GE Vernova Declines 6% as AI Power Stocks Give Back Monday's Rally; Vertiv Drops 4%, Quanta Services Slides 2%
BearishNov 10Terrestrial Energy Q3FY26 Results: Cash holds at $276.3M, launches gas bridge
Leans bearishNov 10Corning to Caterpillar: The AI ‘Picks and Shovels’ Trade Caves In
BearishNov 10Gain Therapeutics Q3 Results: EPS loss narrows to $(0.07), beats estimate
BearishNov 1035 macro signals shaping GEV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
